LBT Innovations Limited
Adelaide
About LBT Innovations Limited
Medical technology company commercialising the first and only FDA cleared instrument using Artificial Intelligence (AI) which automates reading of culture plates in hospitals and microbiology laboratories globally. This first in class technology has US-FDA, CE Mark and TGA regulatory clearances and is available for sale in the United States, the European Union and Australia. The AI algorithm and intelligent imaging platform technology is patent protected, clinically proven through a 10,000 patient clinic trial with reference customer sites established in the US, EU and AU, with early sales.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.5M
- Funding stage: IPO
- Last round: Post-IPO Debt (Feb 2018)
- Ticker: asx:LBT
- Website: lbtinnovations.com
- Phone: +61 (08) 8227 1555
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/lbt-innovations-limited-2242116 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.